Company: NCEL
Filing Date: 2025-06-09
Form Type: F-4/A
Source: 0001213900-25-052354
Chunk: 663

Company: NewcelX Ltd.
Filing Date: 2025-06-09
Form: F-4/A
Chunk 663
---
 an injunction, specific performance and other equitable relief to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof, this being in addition to any other remedy to which such party is entitled at law or in equity. Each of the parties hereby further waives (a) any defense in any action for specific performance that a remedy at law would be adequate and (b) any requirement under any law to post security as a prerequisite to obtaining equitable relief. Annex B-5 19. Counterparts .This Agreement may be executed in two or more counterparts, all of which shall be considered one and the same instrument and shall become effective when one or more counterparts have been signed by each of the parties and delivered to the other party. 20. .pdf Signature .This Agreement may be executed by .pdf signature and a .pdf signature shall constitute an original for all purposes. [The remainder of this page is intentionally left blank.] Annex B-6

SCHEDULE A IN WITNESS WHEREOF, the Company and the Shareholders have caused to be executed or executed this Agreement as of the date first written above.

| NLS PHARMACEUTICALS LTD. |     |                         |
| By:                      |     |                         |
| Name:                    |     | Alex Zwyer              |
| Title:                   |     | Chief Executive Officer |
| Shareholder:             |     |                         |
| By:                      |     |                         |
| Name:                    |     |                         |
| Title:                   |     |                         |

Annex B-7

Annex C Form of Kadimastem Support Agreement [date] To: Kadimastem Ltd. Re: Voting Commitment and Transaction Support The undersigned is the holder of [__]Ordinary Shares, with no par value (the “Shares”) of Kadimastem Ltd. (the “Company”). We understand that the Company is intensively negotiating a transaction the structure of which is described on the Term Sheet attached hereto as Exhibit Ato this letter (with such changes as may be required for tax or corporate compliance issues, the “Transaction”). We further understand that a condition for approving the transaction is to receive shareholders approval at the shareholders meeting that will be convened before closing. In light of the above, the undersigned hereby commits to (i) vote in favor of the Transaction at any meeting of the shareholders of the Company whereby the approval of the Transaction is sought, (ii) not to take any steps or actions that would undermine or